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Abstract
Background: Although law is established on a strong presumption that persons younger than a certain age are
not competent to consent, statutory age limits for asking children’s consent to clinical research differ widely
internationally. From a clinical perspective, competence is assumed to involve many factors including the
developmental stage, the influence of parents and peers, and life experience. We examined potential
determining factors for children’s competence to consent to clinical research and to what extent they explain
the variation in competence judgments.
Methods: From January 1, 2012 through January 1, 2014, pediatric patients aged 6 to 18 years, eligible for clinical
research studies were enrolled prospectively at various in- and outpatient pediatric departments. Children’s competence
to consent was assessed by MacArthur Competence Assessment Tool for Clinical Research. Potential determining child
variables included age, gender, intelligence, disease experience, ethnicity and socio-economic status (SES). We used
logistic regression analysis and change in explained variance in competence judgments to quantify the contribution of a
child variable to the total explained variance. Contextual factors included risk and complexity of the decision to
participate, parental competence judgment and the child’s or parents decision to participate.
Results: Out of 209 eligible patients, 161 were included (mean age, 10.6 years, 47.2 % male). Age, SES, intelligence,
ethnicity, complexity, parental competence judgment and trial participation were univariately associated with
competence (P < 0.05). Total explained variance in competence judgments was 71.5 %. Only age and intelligence
significantly and independently explained the variance in competence judgments, explaining 56.6 % and 12.7 % of the
total variance respectively. SES, male gender, disease experience and ethnicity each explained less than 1 % of the
variance in competence judgments. Contextual factors together explained an extra 2.8 % (P > 0.05).
Conclusions: Age is the factor that explaines most of to the variance in children’s competence to consent, followed by
intelligence. Experience with disease did not affect competence in this study, nor did other variables.
Clinical trial registration: Development and use of a standardized instrument for assessing children’s competence to
consent in drug trials: Are legally established age limits valid?, NTR3918.
Background
More pediatric drug trials are needed, however, historic-
ally the protection of children from research was often
translated as simply excluding them from research [1].
Research with this vulnerable population involves unique
ethical and legal considerations. Little is known about
children’s capacities to meaningfully decide on research
participation. Most laws present age limits for children
to exercise their patient rights, however in pediatric
practice age limits often do not reflect the ability of an
individual child [2]. For clinicians and pediatric investi-
gators it is critical to strike a proper balance in order
both to protect children’s interests when they are not
fully able to do so themselves and to respect their auton-
omy when they are.
Competence is task- and context specific [3], and a
competent decision is required for a valid informed con-
sent next to voluntariness and being well informed.
Strictly speaking incompetence denotes a legal status
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that in principle should be determined by a court. How-
ever resorting to judicial review in every case of sus-
pected incompetence would very heavily burden both
the medical and legal systems, therefore there is good
reason to continue the traditional practice of having
clinicians determine patients’ competence [4]. In clinical
practice competence is generally addressed as decision-
making capacity [5], and in this article we use the terms
interchangeably, referring to clinical assessment of cap-
acity and not legal determination of competence [5].
Children are not accorded the presumption of compe-
tence in most jurisdictions. Although age is frequently
assumed to be the best feasible parameter to assess chil-
dren’s competence to consent, internationally the statu-
tory age limits for asking children’s consent to research
participation differ widely from 12 to 18 years of age [6].
In the Dutch case, regarding clinical research participa-
tion, a double informed consent (child and parent) is re-
quired for minors from the age of 12 until 18. Children
younger than the set age limit are considered by defin-
ition incompetent to act for themselves, they can express
affirmative agreement by giving assent [7]. Previous
studies have shown that age is at best a proxy for devel-
opmental capacity [8–10] and other key determining
factors are highlighted. Cognitive development, experi-
ence, dependence on parents, and peer influences are
the child-specific factors described in previous work [2].
Additionally, the impact of the level of complexity and
risk of the decision, ethnicity and socioeconomic status
(SES) are mentioned in literature [2, 11] to be potential
determining factors.
In our present study we examine which are key deter-
mining factors for children’s competence to give informed
consent to clinical research.
Methods
Patient population
The details of the study participants and baseline charac-
teristics are comprehensively described elsewhere [12].
Briefly, between January 1, 2012 and January 1, 2014 a
cohort of 161 pediatric inpatients and outpatients between
6 and 18 years of age were enrolled, visiting hospitals in
Amsterdam, Rotterdam and The Hague (the Netherlands).
Inclusion criteria were eligibility for clinical research par-
ticipation and speaking Dutch. The clinical research pro-
jects at offer were 10 randomized controlled trials and
three observational studies at departments of allergology,
oncology, pulmonology, ophthalmology and gastroenter-
ology. The study protocol was approved by the institu-
tional review boards at each site. Prior written informed
consent was obtained from the parents or guardians of the
children who served as participants, and of participants
12 years or older, and assent form participants under
12 years of age.
Methods
Children’s competence was assessed by the MacArthur
Competence Assessment Tool for Clinical Research
(MacCAT-CR) interview. The MacCAT-CR guides clini-
cians and patients through the process of information
disclosure required for informed consent, combined with
an assessment of the patient’s capacities, in approxi-
mately fifteen to twenty minutes. The MacCAT-CR
offers a structured overview of patients’ capacities on
four subscales (understanding, appreciation, reasoning,
expressing a choice) to base a competence judgment on.
The Dutch version of MacCAT-CR was modified for
children by using simple language to be understood by
children of elementary school age, and adding questions
on the influence of social relationships [2]. The version
used will be available after arrangement of proprietary
issues. We demonstrated that children’s competence to
consent to clinical research can reliably and validly be
assessed by using the MacCAT-CR [12].
A MacCAT-CR competent classification was consid-
ered present when at least two out of three of the
experts rated the MacCAT-CR interview positive for
competence, in other cases patients were classified
incompetent. Additional patient data were collected,
demographic characteristics included ethnicity. Num-
ber of trials previously participated in and duration of
disease were measures used to express disease experi-
ence. Disease experience was arbitrarily categorized as
low (no prior trial participation and duration of dis-
ease less than one month), moderate (no prior trial
participation and duration of disease more or equal to
one month) or high (prior trial experience). The level
of education of the highest educated parent served as an
indicator of SES, which we categorized: low (no primary
school, primary school, special primary school, special sec-
ondary school); middle (preparatory secondary vocational
education, secondary vocational education, senior general
secondary school, preparatory scientific education); high
(college, university). Complexity of the decision was cate-
gorized into subgroups by consensus between three
researchers (LG, IH, PT): low (open trial or randomized
trial without blinding), or high (randomized trial with
either the use of placebo, or blinding, or both). Risk was
categorized using the same manner: low (no risk), moder-
ate (little risk) or high (possible risk). Cognitive capacities
were expressed as intelligence quotient (IQ) and assessed
by the Wechsler Nonverbal Scale of Ability short version
(WNV). The WNV was administered by trained certified
professionals (special education or psychology graduates)
under supervision of a senior professional. Scores on the
WNV could be categorized into three IQ categories: low
(under 90), average (90–110) or high (110 or higher). Eth-
nicity was classified as Western European, Middle East,
Surinam/Antillean or other.
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Parent(s) were asked if they judged their child had the
capacities to make a well-considered decision on giving
informed consent, in other words, if they considered
their child decision-making competent. We classified if
the child decided to participate in the research project at
offer or not, or if he/she had not decided yet.
Data analysis
Effects of the child variables and contextual variables on
a competence judgment were expressed with odds ratios
(OR) and their 95 % confidence intervals obtained by
simple logistic regression. ORs > 1 indicate higher odds of
a competent judgment when a characteristic is present,
ORs <1 a lower odds. We considered the following child
variables that may “cause” a competent classification: age,
gender, intelligence, disease experience, SES, ethnicity.
Contextual variables considered were complexity, risk, par-
ental competence judgment and decision to participate in a
study. First, we entered all child variables simultaneously
into a multiple logistic model to examine their association
with a competent judgment as expressed by the Wald-test
statistic and associated p-value. Then, we entered the child
characteristics one by one into a new logistic regression
model, the variable with the largest Wald statistic from the
full model first, then the variable with the second largest
Wald statistic and so on. To evaluate the independent con-
tribution to the total explained variance in competent clas-
sifications for a child variable, we examined the increase in
Nagelkerke R-square explained variance after entering a
variable into the model. The influence of the contextual
variables, was examined by the extra increase in R-square
explained variance after adding them to the model that
already included the child characteristics.
Results
Baseline characteristics
Characteristics of the study participants were described
elsewhere [12], we will give a brief overview: of the 209
eligible children eligible for this study, 161 were enrolled,
mean age 10.6 years (range, 6–18).
Association of variables with competence
The distribution of the child and contextual variables
are shown in Table 1. A higher age, higher SES, aver-
age or above average IQ, Western ethnicity, a less
complex decision, a parental judgment of competence
and a positive decision to participate in research were
variables positively associated with competence to
consent (P < 0.05).
Contribution of variables to competence
The contribution of each variable to the total explained
variance in competent judgments is listed in Table 2. Age
alone explained 56.4 % of the variance and IQ added
another 12.7 % totaling 69.1 % explained by these two
variables. SES (1.5 %), gender (0.5 %), disease experience
(0.3 %) and ethnicity (0.1 %) together added another 2.4 %
to a total of 71.5 % of the variance in competent judg-
ments. The contextual variables (not in table) were all not
significant and explained together less than 3 % extra in
explained variance.
Discussion
Results showed that age is the key factor that explains
most of the variance in children’s competence to con-
sent. IQ is the second important contributing factor.
Other factors that could potentially make a causal con-
tribution (gender, disease experience, SES, ethnicity) did
not add significantly to the explained variance in compe-
tence judgments, nor did the contextual factors.
The high contribution of age for children’s competence
to consent complements to recent findings on age limits
[12]. Earlier work showed that competence to consent
was unlikely in children younger than 9.6 years and in
those older than 11.2 years, competence was probable
[12]. These findings offer underpinnings for appropriate
age limits in policies regarding children’s consent.
Cognitive development was described in theoretic litera-
ture to play a major role in children’s competence [10]. In
our present study cognitive functioning expressed in an
IQ explained a substantial part of the remaining variance
in competent classifications after accounting for age. High
intelligence in young children who are generally not
accorded the presumption of competence may be a reason
to doubt incompetence and require individual competence
assessment, as well as low intelligence in children who are
legally accorded competence to consent.
Against our expectations, experience with disease was
not associated with competence in this study. Although
some authors describe that children with personal experi-
ences of illness can obtain greater insight and understand-
ing than children of comparable age without these
conditions [13], others argue that children with chronic
medical disorders or life-threatening diseases might experi-
ence more difficulties in adaptation, social integration,
treatment adherence, and development of autonomy than
children without these conditions [14, 15]. One possible ex-
planation of our findings is that these effects outweigh each
other.
Complexity and risk of the decision did not demon-
strate impact on competence judgments, although most
authors agree that decisions concerning higher potential
risk and more complexity frequently require a higher
level of competence [13]. We consider that providing a
clear explanation of the research procedures might
counteract the impact of the level of risk and the com-
plexity of the research on children’s competence. Or, the
complexity and risks involved are intrinsically weighted
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with age and cognition of a child in a competence judg-
ment. When corrected for these major contributing vari-
ables the influence of complexity and risk to competence
should be negligible.
The finding that SES and ethnicity did not demonstrate
associations with competence indicates that generalizability
of competence studies in populations of different ethnicity
and SES might be possible.
A positive parental competence judgment was associ-
ated with a 10-fold higher odds of a competence deci-
sion (Table 1), however parents judged their children
more easily competent than the experts did. Our results
show that parents express a high expectation regarding
their children’s competence, allotting them more voice
and responsibility than professionals would. Or articu-
lated contrariwise, professional standards might be more
precautionary than parents’ judgments in children’s com-
petence assessment.
Limitations
A limitation may be caused by the somewhat arbitrary
decision to combine studies into low, middle or high
classifications of complexity and risk. Unfortunately
levels of risk and complexity are not yet well defined or
Table 1 Distribution of variables among competent and incompetent children
Total Competent Incompetent Odds ratio P
(N = 161) (n = 100) (n = 61) (95 % CI)
Mean age in years (SD) 10.6 (2.8) 12.4 (2.4) 8.9 (1.6) 2.70 (1.96-3.71)a <0.001
Male gender, N (%) 76 (47) 44 (44) 32 (53) 0.71 (0.38-1.35) 0.30
IQ, N (%)
Lowb 52 (32) 24 (24) 28 (46) 1.00 -
Average 66 (41) 44 (44) 22 (36) 2.33 (1.11-4.93) 0.03
High 43 (27) 32 (32) 11 (18) 3.39 (1.41 -8.15) 0.06
Disease experience, N (%)
Lowb 49 (30) 31 (31) 18 (30) 1.00 -
Medium 74 (46) 44 (44) 30 (49) 0.85 (0.41-1.80) 0.67
High 38 (24) 25 (25) 13 (21) 1.12 (0.46-2.71) 0.81
SES, N (%)
Lowb 18 (11) 6 (6) 12 (20) 1.00
Middle 76 (47) 47 (47) 29 (48) 3.20 (1.10 - 9.6) 0.03
High 67 (42) 47 (47) 20 (33) 4.70 (1.55-14.3) 0.006
Ethnicity, N (%)
Western Europeanc 91 (56) 64 (64) 27 (44) 1.00 -
Othera 70 (44) 36 (36) 34 (56) 0.45 (0.23-0.86) 0.02
Complexity, N (%)
Lowb 36 (22) 31 (31) 5 (8) 1.00 -
High 125 (78) 69 (69) 56 (92) 0.12 (0.07-0.55) 0.001
Risk, N (%)
Low/moderateb 145 (90) 88 (90) 55 (91) 1.00 -
High 16 (10) 10 (10) 6 (10) 1.02 (0.35 -2.96) 0.60
Parental competence judgment
Incompetentb 34 (21) 7 (7) 27 (45) 1.00 -
Competent 125 (79) 92 (93) 33 (55) 10.8 (4.3-27.0) <0.001
Decision to participate
No 62 (39) 34 (34) 28 (47) 1.00 -
Yes 64 (40) 48 (48) 16 (27) 2.5 (1.2-5.3) 0.02
Do not know 34 (21) 18 (18) 16 (27) 0.9 (0.4-2.1) 0.86
aOdds ratio for a competent judgment per year older
bReference category, parental judgment 2 missings, decision to participate 1 missing
cOther: Middle East (30 %), Surinam/Antilles (13 %) and “other”(1 %)
Hein et al. BMC Medical Ethics    Page 4 of 6
quantifiable [16, 17]. The same limitation is valid for
combining trial experience and duration of illness. Both
familiarity with having a chronic disease as well as prior
research participation are supposed to add to the child’s
experience, but levels of experience are not well defined
in literature either.
Conclusion
The demonstrated major role of age explaining variance
in children’s competence to consent to clinical research,
together with the previously estimated age limits for chil-
dren’s competence to consent, provide scientific underpin-
nings for proposals to modify the regulations regarding
children’s consent. As age limits for asking children’s con-
sent vary considerably between countries [6], possible
practical implications of this study’s results that take into
account legal, ethical, developmental and clinical perspec-
tives need to be considered in that context. Advantages
and drawbacks of standardized competence assessment in
children on a case-by-case basis compared to application
of a fixed age limit based on empirical evidence need fur-
ther discussion (see also submitted manuscript, December
2014, IH, PT, GM, MdV, JvG, RJL). Furthermore, future
research is needed to examine children’s competence to
consent in the treatment context.
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